ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE Amex: BTX) announced today that BioTime’s CEO Dr. Michael West will present the keynote address at the BIT Life Sciences’ 3rd Annual World Congress of Regenerative Medicine & Stem Cells 2010 in Shanghai, China on December 5, 2010. Dr. West’s presentation will be titled “Regenerative Medicine: A Force for Change in Biotechnology.” During his talk, Dr. West will present a group of new research products that the Company’s subsidiary Embryome Sciences, Inc. will be launching beginning December 15, 2010. The new products will include 31 new human embryonic progenitor cell lines, associated cell culture media, 53 diverse extracellular matrices, and 62 diverse extracts from conditioned media, all of which will be offered for research use only. Additional information about these new products will be found at www.embryome.com beginning with product launch. Dr. West’s presentation will be available on BioTime’s website at www.biotimeinc.com.
